Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, Aug. 23, 2023 (GLOBE NEWSWIRE) -- The "North America Obesity Intervention Devices Market Size, Share & Industry Trends Analysis Report By End User (Hospitals and Clinics & Others),...
-
Dublin, Aug. 13, 2021 (GLOBE NEWSWIRE) -- The "Gastric Balloons and Bands Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027" report has been added to...
-
Dublin, July 16, 2021 (GLOBE NEWSWIRE) -- The "Bariatric Surgery Devices Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026" report has been added to...
-
Dublin, April 29, 2021 (GLOBE NEWSWIRE) -- The "Bariatric Surgery: Global Markets for Services and Devices 2020-2025" report has been added to ResearchAndMarkets.com's offering. This report aims...
-
Dublin, Sept. 28, 2020 (GLOBE NEWSWIRE) -- The "Global Intragastric Balloon Market By Administration, By Type, By Filling Material, By End Use, By Region, Industry Analysis and Forecast, 2020 -...
-
SAN DIEGO, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (Nasdaq: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric...
-
SAN DIEGO, June 19, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (Nasdaq: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric...
-
SAN DIEGO, May 11, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and...
-
SAN DIEGO, May 08, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved...
-
SAN DIEGO, April 28, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...